What's going on with Aphria's new customer / Canndoc has been pioneering Pharma-Grade cannabis for more than 12 years. Over the years, Canndoc provided more than 750,000 doses to 20,000 patients, establishing its position as a venerable player in this global industry, demonstrating significant expertise across the entire value chain from research, cultivation, and processing, to product development and advanced GMP clinical trials pipeline initiation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.